Atlanta, GA – November 20, 2013 – iBrands Corporation (IBRC), http://www.ibrandscorporation.com/, a holding company targeting the merger and acquisition of niche Internet-based brands positioned for rapid growth through proven products, today discusses the market niche for its new acquisition target, Ultra Image, LLC.
Ultra Image LLC is an Internet-based line of beauty and cosmetic products from Europe that own the exclusive distribution rights for the USA. The trademarked product lines are all natural and gluten free targeting a specific niche market who suffer from Celiac disease.
An autoimmune disease, Celiac disease affects 1% of the population in the USA or approximately 3.1 million people. The disease is triggered by Gluten, a protein composite found in foods processed from wheat and other grain-related species. When these people consume gluten, their immune system attacks structures (known as villi) that line the small intestine and are crucial for absorbing nutrients from food. Symptoms can include diarrhea, bloating, weight loss, fatigue, and joint pain. The only way to treat celiac disease is to avoid gluten.
According to Health.com (Oct 31, 2011), “people with celiac disease are accustomed to being on the lookout for gluten in their food, but they should also be aware of the gluten lurking in their cosmetics and toiletries, researchers warned Monday at a national meeting of gastroenterologists in Washington, D.C.”
About iBrands Corporation
iBRANDS CORPORATION (“IBRC”), http://www.ibrandscorporation.com/, is a publicly traded holding company that acquires and operates niche market brands having unique market positioning with substantial upside. Our strategy is executed through the acquisition of proprietary brands having unique market niches with substantial upside growth and providing strong management. A common thread throughout our acquisitions is the application of Internet technology to enhance revenues and optimize margins.
SAFE HARBOR STATEMENT: Except for historical information contained herein, the statements in this release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause a company’s actual results in the future to differ materially from forecasted results. These risks and uncertainties include, among other things, product price volatility, product demand, market competition and risk inherent in the operations of a company.
Paul Smith, 1-866-595-1081
Source: iBrands Corporation
- Mergers, Acquisitions Takeovers
- Investment Company Information
- Celiac disease
- market niche